Veltassa and Postoperative wound infection - a phase IV clinical study of FDA data

Summary:

Postoperative wound infection is reported as a side effect among people who take Veltassa (patiromer sorbitex calcium), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Lasix, and have Hyperkalemia.

The phase IV clinical study analyzes which people have Postoperative wound infection when taking Veltassa. It is created by eHealthMe based on reports of 15,647 people who have side effects when taking Veltassa from the FDA, and is updated regularly.

What is Veltassa?

Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.

What is Postoperative wound infection?

Postoperative wound infection is found to be associated with 663 drugs and 683 conditions by eHealthMe. Check the latest studies of Postoperative wound infection.

On Aug, 04, 2026

15,647 people reported to have side effects when taking Veltassa.
Among them, 25 people (0.16%) have Postoperative wound infection.

Could Veltassa cause Postoperative wound infection?

Among these 25 people:

How long have people been on Veltassa when they have Postoperative wound infection? *

What is the gender of people who have Postoperative wound infection when taking Veltassa? *

female: 40 %
male: 60 %

What is the age of people who have Postoperative wound infection when taking Veltassa? *

What are other drugs people take besides Veltassa? *

What are other side effects people have besides Postoperative wound infection? *

Constipation: 10 people, 40.00%
Blood Magnesium Decreased: 6 people, 24.00%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 6 people, 24.00%
Skin Exfoliation (removal of the oldest dead skin cells): 6 people, 24.00%
Rashes (redness): 6 people, 24.00%
Rash Pruritic (redness with itching): 6 people, 24.00%
Hypersensitivity: 6 people, 24.00%
Swelling: 5 people, 20.00%
Urinary Tract Infection Staphylococcal: 3 people, 12.00%
Hip Fracture: 3 people, 12.00%

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 25 people, 100.00%
Pain: 3 people, 12.00%
Swelling: 1 person, 4.00%
Mitral Valve Disease (disease of mitral valve of heart): 1 person, 4.00%
Heart Rate Irregular: 1 person, 4.00%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.00%
Cardiac Disorder: 1 person, 4.00%
Blood Pressure Abnormal: 1 person, 4.00%
Back Pain: 1 person, 4.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Veltassa and have Postoperative wound infection?

- Check whether Postoperative wound infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Veltassa:

Veltassa (15,649 reports)

Browse all side effects of Veltassa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Postoperative wound infection:

Postoperative wound infection (663 drugs)

Browse all the conditions that are associated with Postoperative wound infection:

Postoperative wound infection (683 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on patiromer sorbitex calcium (the active ingredients of Veltassa) and Veltassa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.